Healthcare -
Biotechnology - AMEX - US
$ 1.55
-5.3 %
$ 4.31 M
Market Cap
-0.04
P/E
TOVX - COST OF REVENUE
Cost of Revenue TOVX - Theriva Biologics, Inc.
135 K
LAST VALUE
24.57%
2 YEAR CAGR
-13.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR